Page 208 - 80 guidelines for the treatment of malaria_opt
P. 208

nd
              Guidelines for the treatment of malaria – 2  edition


            transfusion  36, 45, 46
            tranmission (settings)
                  high  8, 12, 26, 35, 37, 45, 51, 54, 112, 114, 125, 128
                  low(-to-moderate)  7, 11, 26, 30, 35, 45, 47, 51, 54, 109, 111, 112, 114, 125, 129
                  stable/unstable  5, 12, 32
            travellers  1, 5, 30–32, 193
            treatment
                  failure(s)  6, 8, 10, 14–18, 21, 33, 55, 101, 122, 123, 128, 131
                  first-line  16, 18, 24, 26, 30, 32, 52, 131
                  guidelines  2, 3, 9, 23, 61, 63, 65, 67, 71, 72, 131, 135, 145
                  policies  1, 8, 115, 131
                  pre-referral  24, 29, 30, 32, 39, 40, 72, 161
                  protocol  2, 71
                  recommendations  1, 8, 33, 63, 72
                  second-line  18, 19
            U

            uncomplicated (falciparum/vivax)  see malaria
            under five years  10, 12
            unstable malaria  5
            urine  44, 45, 75, 76, 89, 91, 93, 95, 96, 180

            V

            ventilation  46
            vivax malaria  see malaria
            vomiting  3, 4, 17, 20, 22, 23, 34, 65, 66, 74, 76, 78, 80, 87, 88, 90, 91, 93, 96, 98, 99, 124, 136, 137, 138, 140, 141,
                  142, 146, 148, 150, 169, 171, 193
            Y

            young children  1, 5, 9, 11, 20, 22, 28–0, 32, 39, 40, 97, 98

            Z
            zidovudine  25, 33, 88


















   194
   203   204   205   206   207   208   209   210